Search results (15)
« Back to PublicationsT cell engagers: expanding horizons in oncology and beyond.
Journal article
Albayrak G. et al, (2025), British journal of cancer, 133, 1241 - 1249
Sustained cancer-relevant alternative RNA splicing events driven by PRMT5 in high-risk neuroblastoma.
Journal article
Bate-Eya LT. et al, (2025), Molecular oncology, 19, 741 - 763
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity.
Journal article
Liu G. et al, (2023), Communications biology, 6
Immune modulation underpins the anti-cancer activity of HDAC inhibitors.
Journal article
Blaszczak W. et al, (2021), Molecular oncology, 15, 3280 - 3298
Antitumorigenic Effect of Memantine via Interfering Glutamate Metabolism in Mouse 4T1 Breast Tumor Model.
Journal article
Albayrak G. et al, (2021), Anti-cancer agents in medicinal chemistry, 21, 1575 - 1580
Memantine shifts cancer cell metabolism via AMPK1/2 mediated energetic switch in A549 lung cancer cells.
Journal article
Albayrak G. and Demirtas Korkmaz F., (2021), EXCLI journal, 20, 223 - 231
Targeting Cancer Cell Metabolism with Metformin, Dichloroacetate and Memantine in Glioblastoma (GBM).
Journal article
Albayrak G. et al, (2021), Turkish neurosurgery, 31, 233 - 237
Bortezomib synergizes with nocodazole in p53 mediated DNA damage response signalling in A549 lung cancer cells
Journal article
Albayrak G., (2021), Journal of Research in Pharmacy, 25, 287 - 291
Alzheimer's drug Memantine inhibits metastasis and p-Erk protein expression on 4T1 breast cancer cells.
Journal article
Albayrak G. and Korkmaz FD., (2020), Bratislavske lekarske listy, 121, 499 - 503
The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol.
Journal article
Albayrak G. et al, (2019), Journal of cellular biochemistry, 120, 10564 - 10571
The Importance of Cancer Stem Cells in Gastrointestinal Cancers.
Journal article
Dindar DA. et al, (2019), Critical reviews in oncogenesis, 24, 55 - 59
Memantine induces apoptosis and inhibits cell cycle progression in LNCaP prostate cancer cells.
Journal article
Albayrak G. et al, (2018), Human & experimental toxicology, 37, 953 - 958
FOXA1 knock-out via CRISPR/Cas9 altered Casp-9, Bax, CCND1, CDK4, and fibronectin expressions in LNCaP cells.
Journal article
Albayrak G. et al, (2018), Experimental biology and medicine (Maywood, N.J.), 243, 990 - 994
Do the expressions of epithelial-mesenchymal transition proteins, periostin, integrin-α4 and fibronectin correlate with clinico-pathological features and prognosis of metastatic castration-resistant prostate cancer?
Journal article
Konac E. et al, (2017), Experimental biology and medicine (Maywood, N.J.), 242, 1795 - 1801